Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Severe Combined Immune Deficiency (SCID) to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Severe Combined Immune Deficiency (SCID) to Genetic Disorders Clinical Trials 19
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profile Snapshots 33
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 78

List of Tables
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Proportion of Severe Combined Immune Deficiency (SCID) to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 16
Severe Combined Immune Deficiency (SCID) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Severe Combined Immune Deficiency (SCID) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Severe Combined Immune Deficiency (SCID) to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 20
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Severe Combined Immune Deficiency (SCID) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

List of Figures
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Proportion of Severe Combined Immune Deficiency (SCID) to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 15
Severe Combined Immune Deficiency (SCID) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Severe Combined Immune Deficiency (SCID) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Severe Combined Immune Deficiency (SCID) to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 19
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Severe Combined Immune Deficiency (SCID) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Severe Combined Immune Deficiency (SCID) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30
Severe Combined Immune Deficiency (SCID) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32
GlobalData Methodology 77

Companies Mentioned
- GlaxoSmithKline Plc
- Pharmaceutical Product Development LLC
- Orchard Therapeutics Ltd
- Creat Group Corp
- Chimerix Inc
- Caladrius Biosciences Inc
- Bellicum Pharmaceuticals Inc
- Alexion Pharmaceuticals Inc
- acromion GmbH
- AbbVie Inc